DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ILX23-7553
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vitamin D receptor agonist
ILX23-7553
×
Maximum Phase:
1
First Approval:
None
UNII:
O13QTC8612
Molecule Type:
Small molecule
Molecular Formula:
C27H38O3
Molecular Weight:
410.6
AlogP:
4.85
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
URAPIDIL HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Aneurysm, Dissecting
Unknown
URAPIDIL HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
PVU92PZO12
Molecule Type:
Small molecule
Molecular Formula:
C20H30ClN5O3
Molecular Weight:
423.95
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ILS-920
1
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
ILS-920
×
Maximum Phase:
1
First Approval:
None
UNII:
F2D5P81X82
Molecule Type:
Small molecule
Molecular Formula:
C58H88N2O14
Molecular Weight:
1037.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
BDTX189
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 negative allosteric modulator
BDTX189
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29ClN6O4
Molecular Weight:
561.04
AlogP:
4.84
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
11.0
Source:
KW-2478
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
Unknown
KW-2478
×
Maximum Phase:
1
First Approval:
None
UNII:
QY50S617NM
Molecule Type:
Small molecule
Molecular Formula:
C30H42N2O9
Molecular Weight:
574.67
AlogP:
2.27
PSA:
127.23
HBD:
2.0
HBA:
#RotB:
16.0
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INDIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Tubulin inhibitor
INDIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
80K4H2RB8P
Molecule Type:
Small molecule
Molecular Formula:
C22H16ClN3O2
Molecular Weight:
389.84
AlogP:
4.56
PSA:
63.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ONAPRISTONE
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Prostatic Neoplasms
Progesterone receptor antagonist
ONAPRISTONE
×
Maximum Phase:
1
First Approval:
None
UNII:
H6H7G23O3N
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO3
Molecular Weight:
449.64
AlogP:
5.16
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISOGATINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
FISOGATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
5Q7R99CKV2
Molecule Type:
Small molecule
Molecular Formula:
C24H24Cl2N4O4
Molecular Weight:
503.39
AlogP:
4.49
PSA:
94.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MK-3281
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-3281
×
Maximum Phase:
1
First Approval:
None
UNII:
3593C180JO
Molecule Type:
Small molecule
Molecular Formula:
C29H37N3O3
Molecular Weight:
475.63
AlogP:
5.31
PSA:
57.94
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GDC-0917
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
GDC-0917
×
Maximum Phase:
1
First Approval:
None
UNII:
KWH46ZDG32
Molecule Type:
Small molecule
Molecular Formula:
C29H36N6O4S
Molecular Weight:
564.71
AlogP:
4.07
PSA:
129.46
HBD:
3.0
HBA:
#RotB:
9.0
Source:
R-306465
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
R-306465
×
Maximum Phase:
1
First Approval:
None
UNII:
5WD7KK1IIQ
Molecule Type:
Small molecule
Molecular Formula:
C19H19N5O4S
Molecular Weight:
413.46
AlogP:
1.26
PSA:
115.73
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
AZD6280
1
Small molecule
Investigational
Unknown
Unknown
Anxiety
GABA receptor alpha-2 subunit positive allosteric modulator
AZD6280
×
Maximum Phase:
1
First Approval:
None
UNII:
B9Z1OEH19D
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O3
Molecular Weight:
366.42
AlogP:
3.04
PSA:
99.36
HBD:
2.0
HBA:
#RotB:
6.0
Source:
XANOMELINE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Muscarinic acetylcholine receptor M1 agonist
XANOMELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9ORI6L73CJ
Molecule Type:
Small molecule
Molecular Formula:
C14H23N3OS
Molecular Weight:
281.43
AlogP:
3.22
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
7.0
Source:
AZD-4573
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-4573
×
Maximum Phase:
1
First Approval:
None
UNII:
E5XSP3X68B
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClN5O2
Molecular Weight:
429.95
AlogP:
3.81
PSA:
88.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
L-FUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-FUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
28RYY2IV3F
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BMS-986158
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Primary Myelofibrosis
Bromodomain and extra-terminal motif (BET) inhibitor
BMS-986158
×
Maximum Phase:
1
First Approval:
None
UNII:
X8BW0MQ5PI
Molecule Type:
Small molecule
Molecular Formula:
C30H33N5O2
Molecular Weight:
495.63
AlogP:
5.54
PSA:
77.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AZD-1390
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
AZD-1390
×
Maximum Phase:
1
First Approval:
None
UNII:
CI43QFE22O
Molecule Type:
Small molecule
Molecular Formula:
C27H32FN5O2
Molecular Weight:
477.58
AlogP:
4.93
PSA:
65.18
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PF-04620110
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
PF-04620110
×
Maximum Phase:
1
First Approval:
None
UNII:
CQ4M18RLJW
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O4
Molecular Weight:
396.45
AlogP:
2.85
PSA:
118.64
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PAC-1
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Glioblastoma; Neuroendocrine Tumors
Unknown
PAC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
9LIS8N0B2C
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O2
Molecular Weight:
392.5
AlogP:
2.39
PSA:
68.17
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TUCARESOL
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
TUCARESOL
×
Maximum Phase:
1
First Approval:
None
UNII:
JH368G5B9M
Molecule Type:
Small molecule
Molecular Formula:
C15H12O5
Molecular Weight:
272.26
AlogP:
2.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
PF-04776548
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
PF-04776548
×
Maximum Phase:
1
First Approval:
None
UNII:
CBR15S3HNJ
Molecule Type:
Small molecule
Molecular Formula:
C18H16FN3O3
Molecular Weight:
341.34
AlogP:
2.62
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AZELOPRAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZELOPRAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
MIR2G6L61B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N3O4S
Molecular Weight:
429.54
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
58
59
60
61
62
63
64
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA